Renal Cancers Active Not Recruiting Phase 2 Trials for Pazopanib (DB06589)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01217931Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialTreatment
NCT01392183Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)Treatment